Invent Medic Sweden AB (publ) (“Invent Medic” or the “Company”) is carrying out a rights issue of shares amounting to approximately SEK 13.4 million before issuance costs (the “Rights Issue”). The proceeds from the Rights Issue are primarily intended to be used for sales and marketing efforts, an expanded collaboration with non-governmental organizations, and continued active work on the Company’s acquisition strategy. Subscription commitments and guarantee undertakings amount to approximately SEK 8 million, corresponding to about 60 percent of the Rights Issue. The subscription period for the Rights Issue runs from September 19 to October 3, 2024.
You can find Invent Medic’s full press release here.
Background and Rationale
In 2024, the Company continued to expand its network of distributors in Europe for Efemia Bladder Support, adding new distributors in Poland, Spain, Malta, Denmark, and Hungary. In Sweden, where the Company manages sales directly, Efemia Bladder Support has been procured for prescription in all 21 healthcare regions. The focus in Sweden is on educating healthcare professionals so that they feel confident in recommending and prescribing Efemia Bladder Support, making it the first choice for women with stress urinary incontinence.
Furthermore, UriCap Female was introduced to the Swedish market in spring 2024. The Company is now in discussions with several regions interested in testing and evaluating the product. Regarding FlowCup, the Company shifted its focus in 2024 to primarily working on ongoing NGO projects due to declining profitability in e-commerce. FlowCup has distributed 60,000 menstrual cups to countries with limited access to safe and hygienic menstrual products, often lacking basic sanitation facilities.
The Company has experienced strong growth over the past two years, with sales of Efemia Bladder Support increasing by more than 40 percent in 2024. This growth has occurred while the Company has reduced its costs, significantly improving its financial results. These developments demonstrate that the Company’s initiatives have yielded positive outcomes.
About Invent Medic
Invent Medic is a Swedish FemTech company that enables an active life for all women by offering a broad range of value-creating women’s health products to healthcare providers, non-governmental organizations, and directly to consumers.
Spotlight Stock Market Ticker Symbol: IMS
Corpura acts as financial advisor in connection with the Rights Issue.
For more information:
Christopher Sebök
Phone: +46(0)72-995 43 97
Email: christopher.sebok@corpura.se
